Pahayahay, Novie .
HRN: 20-11-52 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/31/2023
AMPICILLIN 1GM (VIAL)
03/31/2023
04/07/2023
IV
2G
Q6
Pregnancy Uterine 40 3/7 Weeks, In Labor
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes